## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `tesamorelin-nerve-damage`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/tesamorelin-nerve-damage/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tesamorelin-nerve-damage/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tesamorelin-nerve-damage/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/tesamorelin-nerve-damage/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tesamorelin-nerve-damage/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/tesamorelin-nerve-damage/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `tesamorelin-nerve-damage` v2 · content_hash `11599bdead353da2…` · thread_head genesis · 18 DIVs
- **thesis (c1):** An ongoing Phase 2 randomized double-blinded placebo-controlled trial (NCT03150511) is testing tesamorelin for functional recovery after peripheral nerve injury, with estimated completion in 2027 and no results published as of late 2025.
  - c3 [human/active] Tesamorelin is approved for visceral fat reduction in HIV patients and has shown increases in skeletal muscle area and density in treatment responders in second
  - c2 [preclinical/active] In a 2019 rat study, systemic GH after chronic denervation and nerve transfer improved axon density, diameter, myelin thickness, neuromuscular junction reinnerv
  - c4 [anecdotal/active] Reddit users report fluid-retention side effects including wrist pain, tingling, and in one case reactive hypoglycemia while using tesamorelin; one user hoped f
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/tesamorelin-nerve-damage/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/tesamorelin-nerve-damage/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `tesamorelin-nerve-damage`
- **title:** Tesamorelin for Nerve Damage: Evidence Review
- **url:** https://miscsubjects.com/a/tesamorelin-nerve-damage
- **register:** source_ledger
- **updated:** 2026-07-17T02:42:24.259Z
- **tags:** peptide, matrix

## Body

## What's breaking down
Nerve damage often involves axonal disruption after injury, followed by slow or incomplete regeneration. Denervated muscle can atrophy over time because it receives no signals to maintain mass and strength. Repair pathways rely on growth factors and hormones that support axon regrowth and prevent wasting. When these signals stay low, functional recovery stalls even after surgical repair. Degeneration outpaces repair in many cases, leaving persistent sensory loss, weakness, or pain. Tesamorelin fits into discussions of the GH axis because it raises growth hormone levels, and GH has been linked in lab models to better axon regrowth and less muscle loss.

## Why Tesamorelin might help you
1. If your nerve injury leaves muscle without signals, GH elevation is discussed because animal work shows it can limit atrophy during the wait for reinnervation. 2. If axonal regrowth is the bottleneck, the same GH pathway is studied because it appears to support faster axon extension and better myelin thickness in rat models. 3. Therefore for you: If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain. It raises GH via the GHRH receptor, which in turn influences downstream factors tied to nerve and muscle maintenance.

## How these fit together
Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile. Tesamorelin targets the GH axis and its potential effects on visceral fat reduction alongside tissue repair signals. No other peptides are in scope here, so the discussion stays on how GH stimulation might intersect with nerve regeneration layers without overlapping essays on separate compounds.

## What the evidence actually shows
Human data: One ongoing randomized, double-blinded, placebo-controlled Phase 2 trial (NCT03150511) tests tesamorelin after upper-extremity nerve repair. It started in 2018, remains recruiting as of late 2025, and has an estimated primary completion in 2027. No published results exist yet. The trial rationale rests on prior animal findings that GH improves nerve regeneration and functional recovery. Preclinical data: A 2019 rat study used systemic GH after chronic median-nerve denervation followed by nerve transfer. GH-treated rats showed higher axon density, larger axon diameter, thicker myelin, more reinnervated neuromuscular junctions, less muscle atrophy, and stronger grip recovery compared with untreated controls (preclinical tier). No completed human trials demonstrate tesamorelin efficacy for nerve damage. Approved human use of tesamorelin centers on visceral fat reduction in HIV patients, with secondary observations of muscle area and density changes in responders (human tier for that indication).

## What scientists say
Researchers at Johns Hopkins running the ongoing trial note that growth hormone has improved nerve regeneration and reduced muscle atrophy in animal models, forming the basis for testing tesamorelin in patients. They hypothesize faster motor and sensory recovery after surgical repair. Published reviews on peripheral nerve injury mention the trial as an example of growth-hormone-pathway exploration but do not cite outcome data because none are available.

## What people say on Reddit
Anecdotal reports mention hopes for post-surgical nerve growth but no clear personal confirmation of benefit after a cycle. Several users describe fluid-retention effects such as wrist aching, tingling, or carpal-tunnel-like symptoms while on tesamorelin; one linked these to elevated GH and resolved after stopping. Another reported reactive hypoglycemia requiring ER care shortly after starting. These are user experiences only and do not establish cause or efficacy for nerve repair.

## What people say on X
Limited public discussion appears on X specifically tying tesamorelin to nerve-damage outcomes. Searches surface general peptide conversations but no detailed case reports or outcome threads matching the scale of Reddit mentions.

## What we do not know
No human efficacy data exist yet from the Phase 2 trial. Long-term effects on nerve recovery beyond the trial population remain untested. Whether GH elevation from tesamorelin translates to the same benefits seen with direct GH in rats is unknown. Individual responses, optimal timing relative to injury or surgery, and interactions with other conditions are not characterized in published human studies for this use.

## Safety and limits
Tesamorelin carries known side effects including joint pain, fluid retention, and paresthesia in its approved indication. The same fluid-retention mechanism that can produce tingling or carpal-tunnel symptoms in some users is relevant when considering nerve-damage contexts. The ongoing trial monitors safety in post-injury patients, but final data are pending. All information here is for research review only; consult qualified medical professionals for personal health decisions.

## Claims (4)

- **c1** [human w=0.8] An ongoing Phase 2 randomized double-blinded placebo-controlled trial (NCT03150511) is testing tesamorelin for functional recovery after peripheral nerve injury, with estimated completion in 2027 and no results published as of late 2025.
  - who_claims: grok/grok-4.3
  - sources: s1
- **c3** [human w=0.8] Tesamorelin is approved for visceral fat reduction in HIV patients and has shown increases in skeletal muscle area and density in treatment responders in secondary analyses of those trials.
  - who_claims: grok/grok-4.3
  - sources: s3
- **c2** [preclinical w=0.5] In a 2019 rat study, systemic GH after chronic denervation and nerve transfer improved axon density, diameter, myelin thickness, neuromuscular junction reinnervation, reduced muscle atrophy, and grip strength recovery compared with controls.
  - who_claims: grok/grok-4.3
  - sources: s2
- **c4** [anecdotal w=0.3] Reddit users report fluid-retention side effects including wrist pain, tingling, and in one case reactive hypoglycemia while using tesamorelin; one user hoped for post-surgery nerve growth but observed no clear benefit.
  - who_claims: grok/grok-4.3
  - sources: s4, s5

## Voxel graph (4 atoms · 9 edges)
- full graph: https://miscsubjects.com/api/articles/tesamorelin-nerve-damage/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (5)
- chain valid: yes · head: `7f4ca453e9421329`

### s1 · clinical_trial · ok
- title: Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury
- url: https://clinicaltrials.gov/study/NCT03150511
- summary: Ongoing Phase 2 trial details and status.
- quote: The aim of this clinical trial is to evaluate the efficacy of tesamorelin as a therapy for peripheral nerve injuries. ... Recruiting ... Last Update Posted 2025-11-12 ... Primary Completion (Estimated) 2027-12
- claim_ids: c1
- hash: `c92fc5e450195b04`

### s2 · pubmed · ok
- title: Growth Hormone Improves Nerve Regeneration, Muscle Re-Innervation, and Functional Outcomes After Chronic Denervation Injury
- url: https://pmc.ncbi.nlm.nih.gov/articles/PMC6395714/
- summary: 2019 rat study on GH for nerve regeneration.
- quote: GH-treated animals demonstrated enhanced median nerve regeneration as measured by axon density (p < 0.005), axon diameter (p < 0.0001), and myelin thickness (p < 0.0001); improved muscle re-innervation ... reduced muscle atrophy ... greater recovery of motor function
- claim_ids: c2
- hash: `46181b5b77988cd1`

### s3 · pubmed · ok
- title: The Growth Hormone Releasing Hormone Analogue Tesamorelin Decreases Visceral Adipose Tissue...
- url: https://pmc.ncbi.nlm.nih.gov/articles/PMC6766405/
- summary: Human data on muscle effects in HIV patients.
- quote: Tesamorelin was associated with significantly greater increases in density of four truncal muscle groups ... and the lean ... muscles ... Significant increases were also seen in total area of the rectus and psoas muscles
- claim_ids: c3
- hash: `14d3cb51f640124e`

### s4 · reddit · ok
- title: Tesamorelin - no recomp occurring
- url: https://www.reddit.com/r/Peptides/comments/1e4ai7g/tesamorelin_no_recomp_occurring/
- summary: User anecdote on hoped-for nerve benefit.
- quote: My primary goal was to see if I got any nerve growth 1-2 yrs post surgery, but I'm at the end of the cycle and there's just no way to tell
- claim_ids: c4
- hash: `254137c5bf9064c4`

### s5 · reddit · ok
- title: Tesamorelin possibly sent me to the ER
- url: https://www.reddit.com/r/Biohackers/comments/1pjk16m/tesamorelin_possibly_sent_me_to_the_er/
- summary: User report of side effect.
- quote: I became extremely dizzy, anxious, shaky ... blood sugar ... below 40 ... diagnosed with reactive hypoglycemia
- claim_ids: c4
- hash: `7f4ca453e9421329`

## Provenance (2 model passes)
- chain valid: yes · head: `79f378ca2f14f72c`

- write · grok/grok-4.3 · 2026-06-29T23:18 · hash `ae92ddd7ac20`
- voxel_divide · owner · 2026-07-17T02:42 · hash `79f378ca2f14`

## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/tesamorelin-nerve-damage/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/tesamorelin-nerve-damage/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"tesamorelin-nerve-damage","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest tesamorelin-nerve-damage|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim tesamorelin-nerve-damage|tier|assertion`
- **iMessage ask:** `tesamorelin-nerve-damage|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `tesamorelin-nerve-damage`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tesamorelin-nerve-damage/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tesamorelin-nerve-damage/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*